PHSI-BRG
PHSI-BRG
Home
Staff
Sarah Al Ashmori
Andy Bryant
Thomas Chadwick
Svetlana Cherlin
Mike Cole
Holly Fisher
Tony Fouweather
Shaun Hiu
Dorcas Kareithi
Ann Breeze Konkoth
Nan Lin
Jingky Lozano-Kuehne
Helen Mossop
Ellen Moss
Aritra Mukherjee
Jérémie Nsengimana
Vicky Ryan
Marzieh Shahmandi
Moha Shojaei
Dawn Teare
James Wason
Faye Williamson
Nina Wilson
Sylvia Zhang
PhD students
Ruqayya Azher
Nicole Cizauskas
Laura Etfer
Niamh Fitzgerald
Raiann Hamshaw
Pela Okorie
Samuel Sarkodie
Lou Whitehead
Methodology research
Overview
Adaptive designs
Master protocols
Transforming IMID trials
Projects
Publications
News
Courses
Adaptive Designs and Multiple Testing Procedures
Leveraging External Information
Precision Medicine Clinical Trials
Contact
Light
Dark
Automatic
Components of smartphone cognitive-behavioural therapy for subthreshold depression among 1093 university students: a factorial trial
Masatsugu Sakata
,
Rie Toyomoto
,
Kazufumi Yoshida
,
Yan Luo
,
Yukako Nakagami
,
Teruhisa Uwatoko
,
Tomonari Shimamoto
,
Aran Tajika
,
Hidemichi Suga
,
Hiroshi Ito
,
Michihisa Sumi
,
Takashi Muto
,
Masataka Ito
,
Hiroshi Ichikawa
,
Masaya Ikegawa
,
Nao Shiraishi
,
Takafumi Watanabe
,
Ethan Sahker
,
Yusuke Ogawa
,
Steven D Hollon
,
Linda M Collins
,
Edward R Watkins
,
James Wason
,
Hisashi Noma
,
Masaru Horikoshi
,
Taku Iwami
,
Toshi A Furukawa
May 2022
Cite
DOI
URL
Type
Journal article
Publication
Evidence Based Mental Health
Wason
Related
Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK)
Graves-PCD: protocol for a randomised, dose-finding, adaptive trial of the plasma cell-depleting agent daratumumab in severe Graves’ disease
Challenges of designing and conducting cohort studies and clinical trials in populations of pregnant people
Adaptive and innovative study design in rare diseases
Operational complexities in international clinical trials: a systematic review of challenges and proposed solutions
Cite
×